CG ONCOLOGY INC (CGON) Stock Analyst Earnings Estimates
NASDAQ:CGON - Nasdaq - US1569441009 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.358M | 191K -98.16% | 204K 6.81% | 527.003K 158.34% | 419.903K -20.32% | 93.023M 22,053.43% | 198.22M 113.09% | 403.83M 103.73% | 698.36M 72.93% | 1.034B 48.06% | 1.369B 32.40% | 1.802B 31.63% | |
| EBITDA YoY % growth | -12.596M | -35.231M -179.70% | -55.432M -57.34% | -109.395M -97.35% | -172.808M -57.97% | -127.867M 26.01% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -12.606M | -35.246M -179.60% | -55.449M -57.32% | -110.161M -98.67% | -144.754M -31.40% | -137.293M 5.15% | -81.058M 40.96% | 70.996M 187.59% | 303.65M 327.70% | 579.87M 90.97% | 844.02M 45.55% | 1.198B 41.94% | |
| Operating Margin | -121.70% | -18,453.40% | -27,180.88% | -20,903.32% | -34,473.15% | -147.59% | -40.89% | 17.58% | 43.48% | 56.08% | 61.65% | 66.48% | |
| EPS YoY % growth | N/A | N/A | N/A | -1.33 1.80% | -1.86 -39.08% | -1.68 9.34% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 91.48% | -0.42 -15.46% | -0.45 -59.38% | -0.47 -56.40% | -0.52 -38.36% |
| Revenue Q2Q % growth | 65.28K 6,428.00% | 204K -61.44% | 204K 83.78% | 204K 374.42% | 204K 212.50% |
| EBITDA Q2Q % growth | -31.273M -65.34% | -35.527M -58.14% | -40.188M -55.51% | -45.512M -61.03% | -51.592M -64.97% |
| EBIT Q2Q % growth | -32.262M -70.41% | -33.398M -48.64% | -36.482M -41.11% | -39.783M -40.60% | -44.73M -38.65% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.30 | -0.37 | 0.07 | 19.89% |
| Q2 2024 Q2Q % growth | -0.28 | -0.38 | 0.10 | 26.21% |
| Q1 2024 Q2Q % growth | -0.36 | -0.30 | -0.06 | -21.70% |
| Q4 2023 Q2Q % growth | -4.37 | -0.69 | -3.68 | -534.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 43K -78.82% | 106.284K | -63.284K | -59.54% |
| Q2 2024 Q2Q % growth | 111K | 179.857K | -68.857K | -38.28% |
| Q3 2023 Q2Q % growth | 203K 6.28% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.95% | 17.05% | 0.41% | 5.94% |
| Revenue | 495.35% | -63.7% | -16.67% | -49.52% |